Therapeutic strategies in rheumatoid arthritis

被引:0
|
作者
Bastian, H. [1 ]
Feist, E. [2 ]
Burmester, G. -R. [2 ]
机构
[1] Immanuel Krankenhaus Berlin, Abt Rheumatol & Klin Immunol, D-13125 Berlin, Germany
[2] Univ Med Berlin, Charite, Med Klin Schwerpunkt Rheumatol, Berlin, Germany
来源
INTERNIST | 2011年 / 52卷 / 06期
关键词
Rheumatoid arthritis; Disease-modifying antirheumatic drugs; Glucocorticosteroids; Biologics; Non-steroidal anti-inflammatory drugs; DOUBLE-BLIND; CONVENTIONAL RADIOGRAPHY; UNITED-KINGDOM; METHOTREXATE; EFFICACY; PLACEBO; SCINTIGRAPHY; RITUXIMAB; SAFETY; JOINTS;
D O I
10.1007/s00108-010-2765-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis is the most common chronic inflammatory-rheumatic joint disease. If untreated, patients develop radiologically detectable progressive joint destruction. Rheumatoid arthritis has considerable socioeconomic importance, since a majority of patients are affected at employable age and can be significantly disabled over the course of the disease. Therefore, an appropriate early intervention with disease modifying anti-rheumatic drugs as well as ergo- and physiotherapy plays an important role for the prognosis. In the past few years, the introduction of novel drugs has improved the treatment opportunities markedly. This progress was the basis for new treatment strategies of tight disease control with the goal of disease remission.
引用
收藏
页码:645 / +
页数:9
相关论文
共 50 条
  • [21] Leveraging Human Genetics to Develop Future Therapeutic Strategies in Rheumatoid Arthritis
    Plenge, Robert M.
    Raychaudhuri, Soumya
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (02) : 259 - +
  • [22] Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies
    Qin Wang
    Xianyan Qin
    Jiyu Fang
    Xun Sun
    [J]. Acta Pharmaceutica Sinica B, 2021, 11 (05) : 1158 - 1174
  • [23] Recent progress in therapeutic strategies and biomimetic nanomedicines for rheumatoid arthritis treatment
    Li, Chunhong
    Zheng, Xiu
    Hu, Mei
    Jia, Ming
    Jin, Rongrong
    Nie, Yu
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2022, 19 (08) : 883 - 898
  • [24] Focus on biological agents in rheumatoid arthritis: Newer treatments and therapeutic strategies
    Fanet-Goguet, M
    Martin, S
    Fernandez, C
    Fautrel, B
    Bourgeois, P
    [J]. THERAPIE, 2004, 59 (04): : 451 - 461
  • [25] The role of macrophage polarization in rheumatoid arthritis and osteoarthritis: Pathogenesis and therapeutic strategies
    Chang, Jun-Way
    Tang, Chih-Hsin
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
  • [26] Treatment Strategies in Early Rheumatoid Arthritis and Prevention of Rheumatoid Arthritis
    Demoruelle, M. Kristen
    Deane, Kevin D.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (05) : 472 - 480
  • [27] Treatment Strategies in Early Rheumatoid Arthritis and Prevention of Rheumatoid Arthritis
    M. Kristen Demoruelle
    Kevin D. Deane
    [J]. Current Rheumatology Reports, 2012, 14 : 472 - 480
  • [28] Modeling therapeutic strategies in rheumatoid arthritis: Use of decision analysis and Markov models
    Albert, DA
    Aksentijevich, S
    Hurst, S
    Fries, JF
    Wolfe, F
    [J]. JOURNAL OF RHEUMATOLOGY, 2000, 27 (03) : 644 - 652
  • [29] CHALLENGING THE THERAPEUTIC PYRAMID - A NEW LOOK AT TREATMENT STRATEGIES FOR RHEUMATOID-ARTHRITIS
    WILSKE, KR
    HEALEY, LA
    [J]. JOURNAL OF RHEUMATOLOGY, 1990, 17 : 4 - 7
  • [30] Dysfunctions, Molecular Mechanisms, and Therapeutic Strategies of Regulatory T Cells in Rheumatoid Arthritis
    Li, Xiaoya
    Xu, Huihui
    Huang, Jing
    Luo, Dan
    Lv, Shuang
    Lu, Xiangchen
    Xiao, Cheng
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12